Raxorulimogene belzovacirepvec expressed IgGL

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 19:15:22 GMT 2023` Edited by `admin` on `Sat Dec 16 19:15:22 GMT 2023`
Protein Type	PREPROTEIN
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	Z7K8WVV2H3
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Raxorulimogene belzovacirepvec expressed IgGL–T2A-αCTLA4-IgGH

Common Name

English

Raxorulimogene belzovacirepvec expressed anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) immunoglobulin G1 γ1-chain fused via a synthetic T2A peptide with human immunoglobulin kappa chain (anti-CTL4 antibody) with the Igκ signal sequence for

Common Name

English

Code System Code Type Description

FDA UNII

Z7K8WVV2H3

Created by admin on Sat Dec 16 19:15:22 GMT 2023 , Edited by admin on Sat Dec 16 19:15:22 GMT 2023

PRIMARY

Related Record Type Details


					P3D8R5LG7H

Raxorulimogene Belzovacirepvec

VECTOR->EXPRESSED PROTEIN

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
T2A	PROTEIN FEATURE
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL
Igκ signal sequence	PROTEIN FEATURE